MedPath

Exploratory clinical study on the prevention effect of Docetaxel-induced peripheral neuropathy by compression therapy using surgical gloves and lower limb stockings

Phase 2
Recruiting
Conditions
Prostate cancer
Registration Number
JPRN-UMIN000037761
Lead Sponsor
Kagawa university hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
75
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with peripheral neuropathy at the start of the study 2) Patients who have received medication that may cause peripheral neuropathy in the past. 3) Other patients who are judged inappropriate by the research doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Presence of peripheral neuropathy at the end of 10 courses Grade 1 or higher is judged to be peripheral neuropathy, and Grade 0 or higher is judged to be no peripheral neuropathy based on the CTCAE ver 5.0.
Secondary Outcome Measures
NameTimeMethod
Changes in the nails at the end of the 10 courses Based on the CTCAE ver 5.0, the "Peripheral Nerve Damage and Nail Questionnaire" is used to evaluate Grade 1 or higher as nail damage and Grade 0 as no nail damage.
© Copyright 2025. All Rights Reserved by MedPath